Adamed Discovery

Adamed is a leading Polish pharmaceutical and biotechnology company dedicated to the research, development, and manufacture of both innovative and generic medicines. Founded in 1986, the company has transitioned from a local manufacturer to a global player with a presence in over 70 markets worldwide. Through its Adamed Discovery division, the firm focuses on original drug development in the areas of oncology, central nervous system disorders, and metabolic diseases. Adamed operates state-of-the-art R&D centers and manufacturing facilities that comply with international GMP standards, and it was the first Polish company to initiate research on original molecular therapies. The company maintains a robust pipeline of small molecules and biologics while continuing to expand its portfolio of value-added generic products.